Julia Wang
Director of Finance/CFO presso BEIGENE, LTD.
Patrimonio netto: 4 M $ in data 31/03/2024
Posizioni attive di Julia Wang
Società | Posizione | Inizio | Fine |
---|---|---|---|
BEIGENE, LTD. | Director of Finance/CFO | 30/06/2021 | - |
Comptroller/Controller/Auditor | 30/06/2021 | 19/03/2024 | |
Corporate Officer/Principal | 01/06/2020 | 30/06/2021 |
Storia della carriera di Julia Wang
Precedenti posizioni note di Julia Wang
Società | Posizione | Inizio | Fine |
---|---|---|---|
ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2018 | 01/01/2020 |
QUEST DIAGNOSTICS INCORPORATED | Corporate Officer/Principal | 01/01/2015 | 01/01/2018 |
Formazione di Julia Wang
Shandong Normal University | Undergraduate Degree |
The Fuqua School of Business | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 4 |
Cina | 2 |
Isole Cayman | 2 |
Posizioni
Corporate Officer/Principal | 3 |
Comptroller/Controller/Auditor | 1 |
Director of Finance/CFO | 1 |
Settori
Health Technology | 3 |
Consumer Services | 3 |
Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
QUEST DIAGNOSTICS INCORPORATED | Health Services |
BEIGENE, LTD. | Health Technology |
Aziende private | 1 |
---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Julia Wang
- Esperienza